Table 1.

Effects of GVHD on the PB Cells, BM Cellularity, and CFU-GM

PB Cell Counts Total No. of BM Cells (×106) CFU-GM/105
Total Leukocyte (/μL) Hematocrit (%) Platelet (×104/μL)
BDF1  3,150 ± 45 54.1 ± 3.0  69.2 ± 7.4  34.1 ± 1.7 53.8 ± 10.3  
B6/BDF1  2,160 ± 307-150 37.6 ± 0.4-150 23.4 ± 8.7-150 6.2 ± 1.8-150 29.7 ± 7.2-150 
D2/BDF1  3,433 ± 553  51.0 ± 6.2 62.3 ± 5.7  36.0 ± 7.4  54.6 ± 6.4 
PB Cell Counts Total No. of BM Cells (×106) CFU-GM/105
Total Leukocyte (/μL) Hematocrit (%) Platelet (×104/μL)
BDF1  3,150 ± 45 54.1 ± 3.0  69.2 ± 7.4  34.1 ± 1.7 53.8 ± 10.3  
B6/BDF1  2,160 ± 307-150 37.6 ± 0.4-150 23.4 ± 8.7-150 6.2 ± 1.8-150 29.7 ± 7.2-150 
D2/BDF1  3,433 ± 553  51.0 ± 6.2 62.3 ± 5.7  36.0 ± 7.4  54.6 ± 6.4 

The BDF1 mice were injected with either 5 × 107 of B6 spleen cells (B6/BDF1) or 9 × 107 of D2 cells (D2/BDF1). The PB cell counts, BM cellularity, and CFU-GM were examined on day 14 after transfer. The results from three to five mice were expressed as the mean ± SEM.

F0-150

Significant decrease versus the uninjected control BDF1 mice (P < .01).

or Create an Account

Close Modal
Close Modal